Quality of LifeHRQoLNCT06300983
Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being
A study testing Psychoeducative in people with Quality of Life and Myositis, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.
Trial summary
Purpose. Myositis is a rare disease associated with impaired health-related quality of life. A study evaluating the effectiveness of an intervention to improve the quality of life and well-being of myositis patients is presented. Materials and Methods. All myositis patients in a health district are contacted. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Quality of Life, Myositis
- What is being tested?
- Psychoeducative
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 34 participants
- Where
- 1 siteSpain
- Study dates
- 15 Sep 2022to 31 Oct 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Definite diagnosis of myositis according to the International Myositis Classification Criteria (score > 90)
- Ability to understand the purpose and procedures of the study, and motivation and agreement to participate.
Who cannot join
- Do not meet the diagnostic criteria
- Patients hospitalized for an extremely severe illness
- Patients who declined to participate
- Patients who required excessive convincing for participation
- Patients who deemed likely to play a disruptive role in the group
- Patients younger than 18 years
- Patients who had severe psychiatric conditions or had an unfavorable short-term prognosis.
Trial locations and contacts
1 site in 1 country.
Spain1 site
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
Barcelona, 08035
About this study
Official title: Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being: A Randomized Controlled Trial
Purpose. Myositis is a rare disease associated with impaired health-related quality of life. A study evaluating the effectiveness of an intervention to improve the quality of life and well-being of myositis patients is presented.
Materials and Methods. All myositis patients in a health district are contacted. Eligible patients are randomly assigned to the experimental or control group. A psychoeducational intervention of 5 100-min sessions focusing on the disease as related to daily life is conducted only in experimental patients. Several reliable tools to measure quality of life and well-being are administered twice, before and after the intervention, to both groups.
Read the detailed description
Materials and methods The Medical Research Ethics Committee and Research Projects Commission of the Vall d'Hebron University Hospital approved the project [number PR(AG)398/2022]. Attending to circumstances of the intervention and to enhance methodological quality, the study is designed as a randomized controlled trial with a control group and an experimental group, with two measurement time points. The CONSORT statement is followed to conduct the study.
Participants Patients are eligible for enrolment based on the following inclusion criteria.
- a definite diagnosis of myositis according to the International Myositis Classification Criteria (score > 90) and
- the ability to understand the purpose and procedures of the study, and motivation and agreement to participate.
A large cohort of adult myositis patients attending our outpatient clinic (Systemic Autoimmune Diseases Unit of Vall d'Hebron General Hospital, Barcelona, Spain) are potential candidates for the study. Vall d'Hebron General Hospital is a 700-bed referral and teaching hospital for a catchment population of nearly 450,000 inhabitants. Virtually all patients from the area with suspected myositis are referred to Vall d'Hebron, where they are diagnosed, treated, and followed up, whether the disease is severe or not.
All candidate patients are contacted by telephone and invited to participate in the study during a 2-month period. Patients are excluded from the study if they do not meet the diagnostic criteria or are hospitalized for an extremely severe illness, declined to participate, required excessive convincing for participation, deemed likely to play a disruptive role in the group, are younger than 18 years, had severe psychiatric conditions, or had an unfavourable short-term prognosis.
Psychoeducational Intervention The psychoeducational program will be carried out in the experimental group during a two-month period. Control patients do not participate in the intervention, and are treated as usual, and placed on a waiting list to receive the psychoeducational intervention after completion of the study. Patients who receive the intervention had no contact with the control participants. The intervention consists of 5 sessions, with each lasting 100 minutes and delivered on a weekly basis. Individual meetings are conducted with each participant prior to starting the group work. These are considered pre-intervention sessions, during which patients provided informed consent to participate in the study and the first assessment tests is administered.
Two specialized professionals participate in the group sessions: a leader and an external observer present during the process. The leader positioned herself within the group ecology, facilitating the dynamics and development of the sessions. The observer, located outside the group ecology, but in the same room, is responsible for preparing complete minutes of each session and detailed observations, recording the topics discussed and the session structure, as well as presences, absences, delays, and critical incidents, among other relevant data.
The duration and structure of each session is constant, with an introduction phase of 30 minutes, a central phase (the most substantial part of each session) of 50 minutes, and a final phase of 20 minutes. The methodological approach used in the study allow for systematic and consistent implementation of the group psychoeducational program. The combination of individual and group sessions, together with the presence of an external observer, provide a comprehensive view of the progression of the participants and the topics covered.
Measures
Participants are required to fill out a series of questionnaires related with the objectives of the study at 2 time points: before the start of the intervention and on the last day of the intervention. The control group, which do not participate in the intervention, filled out the same questionnaires at the same 2 time points. The battery of questionnaires included the following scales:
World Health Organization Quality of Life Measure (WHOQOL-BREF): a comprehensive, generic questionnaire designed to evaluate various aspects of quality of life. The WHOQOL-BREF consists of 26 items, with 24 items covering four domains: physical health, psychological health, social relationships, and environment. Additionally, 2 global questions inquire about overall quality of life and satisfaction with health. Participants rated each item on a 5-point scale, in which higher scores indicate better quality of life. The assessment was based on the experiences of the past 2 weeks. Results from the 4 domains multiplied by 4 gives a score from 0 to 100, with higher scores indicating better quality of life.
The Spanish version of the WHOQOL-BREF has demonstrated good psychometric properties among elderly Spanish individuals, validating its suitability for the study population.
World Health Organization Well-Being Index (WHO-5): a five-item scale used to assess positive well-being experienced over the past 2 weeks. Each item is rated on a 6-point Likert scale, ranging from 0 (indicating at no time) to 5 (representing all of the time). The total score ranges from 0 to 25. The total multiplied by 4 gives a score from 0 to 100, with higher scores indicating a greater sense of well-being. The WHO-5 has shown high reliability [18].
Self-Efficacy to Manage Chronic Disease Scale (Spanish version, SEMCD-S): developed and validated to assess self-management following an intervention conducted in Stanford University's Chronic Disease Self-Management Program. The questionnaire comprises 4 items, and participants rate each item on a scale from 1 (very unsure) to 10 (very sure). The self-efficacy value is determined as the average of the 4 scores obtained. Higher scores on the scale indicates higher levels of self-efficacy. The questionnaire has shown favorable psychometric properties, indicating good reliability.
International Physical Activity Questionnaire - Short Form (IPAQ) (validated Spanish short-form version). This questionnaire assesses types of physical activity according to their intensity levels and the amount of time spent sitting, as individuals engage in their daily routines. These factors are used to estimate the total physical activity in MET-minutes per week and the duration of sitting time. The tool includes inquiries about 3 types of activity-walking, moderate-intensity activities, and vigorous-intensity activities-performed over the last 7 days, along with a question about sitting time. The overall physical activity (PA) score is obtained by summing up the MET-minutes per week for all 3 types of activities. The study classifies the population into 3 PA levels-low, moderate, and high-following the IPAQ guidelines. Test-retest reliability has indicated good stability.
Participant information encompassed sociodemographic data, which comprised age, sex, marital status, household composition, educational background, and employment status. Clinical data, such as age at diagnosis, specific diagnosis, and years of disease follow-up, were also recorded.
Statistical analysis SPSS version 28 (SPSS Software Inc., Chicago, IL) is used for the statistical analyses. The McNemar test is carried out for nominal dependent variables, and repeated measures ANOVA are used for quantitative variables [22]. Eta squared is used as a measure of effect size. Effect size values around 0.01 are considered a small effect, around 0.06 a medium effect, and around 0.14 a large effect.
- Conditions
- Quality of Life, Myositis
- Being tested
- Psychoeducative, Placebo
- Keywords
- Clinical trial, Inflammatory myopathy, Myositis, Psychoeducational intervention, Health related quality of life
- Medical subject headings
- Myositis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PsychoeducativeBehavioural
The intervention consiste of 5 sessions (Table 1), with each lasting 100 minutes and delivered on a weekly basis. Individual meetings will be conducted with each participant prior to starting the group work. These were considered pre-intervention sessions, during which patients provided informed consent to participate in the study and the first assessment tests were administered.
PlaceboBehavioural
The control group, which do not receive any psychoeducative intervention
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Active comparator | The intervention consisted of 5 sessions, with each lasting 100 minutes and delivered on a weekly basis. Receives: Behavioral: Psychoeducative |
| Control group | Placebo comparator | The control group, which do not receive any psychoeducative intervention Receives: Behavioral: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Health related quality of life
WHOQOL-The WHOQOL-BREF consists of 26 items, with 24 items covering four domains: physical health, psychological health, social relationships, and environment. Additionally, 2 global questions inquire about overall quality of life and satisfaction with health. Participants rated each item on a 5-point scale, in which higher scores indicate better quality of life. The assessment was based on the experiences of the past 2 weeks. Results from the 4 domains multiplied by 4 gives a score from 0 to 100, with higher scores indicating better quality of life.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2024
- Study start15 Sep 2022
- Primary completion31 Oct 2022
- Study completion31 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Quality of LifeStudies of the same condition, open and under way.
- More trials run by Hospital Universitari Vall d'Hebron Research InstituteThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Albert S Selva-O'Callaghan, Prof, Principal investigator, Vall d'Hebron General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06300983
- Sponsor's protocol ID
- PR(AG)398/2022
- Acronym
- HRQoL
- Status last verified
- Mar 2024
- First submitted
- 12 Feb 2024
- Last updated
- 8 Mar 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Armadans-Tremolosa I, Palacin-Lois M, Castrechini-Trotta A, Sanduvete-Chaves S, Chacon-Moscoso S, Selva-O'Callaghan A. Effectiveness of a psychoeducational intervention on myositis patients' quality of life and well-being: a randomized controlled trial. Orphanet J Rare Dis. 2024 Nov 1;19(1):411. doi: 10.1186/s13023-024-03426-0.
PubMed 39487522
Study at a glance
From the registry record, last updated by the sponsor on 8 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06300983
- Acronym / sponsor ID
- HRQoL / PR(AG)398/2022
- Conditions
- Quality of Life, Myositis
- Keywords
- Clinical trial, Inflammatory myopathy, Myositis, Psychoeducational intervention, Health related quality of life
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research InstituteUniversity, hospital or other
- Study start
- 15 Sep 2022 (actual)
- Primary completion
- 31 Oct 2022 (actual)
- Study completion
- 31 Oct 2022 (actual)
- First posted
- 8 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose. Myositis is a rare disease associated with impaired health-related quality of life. A study evaluating the effectiveness of an intervention to improve the quality of life and well-being of myositis patients is presented.
Materials and Methods. All myositis patients in a health district are contacted. Eligible patients are randomly assigned to the experimental or control group. A psychoeducational intervention of 5 100-min sessions focusing on the disease as related to daily life is conducted only in experimental patients. Several reliable tools to measure quality of life and well-being are administered twice, before and after the intervention, to both groups.
Detailed description
Materials and methods The Medical Research Ethics Committee and Research Projects Commission of the Vall d'Hebron University Hospital approved the project [number PR(AG)398/2022]. Attending to circumstances of the intervention and to enhance methodological quality, the study is designed as a randomized controlled trial with a control group and an experimental group, with two measurement time points. The CONSORT statement is followed to conduct the study.
Participants Patients are eligible for enrolment based on the following inclusion criteria.
- a definite diagnosis of myositis according to the International Myositis Classification Criteria (score > 90) and
- the ability to understand the purpose and procedures of the study, and motivation and agreement to participate.
A large cohort of adult myositis patients attending our outpatient clinic (Systemic Autoimmune Diseases Unit of Vall d'Hebron General Hospital, Barcelona, Spain) are potential candidates for the study. Vall d'Hebron General Hospital is a 700-bed referral and teaching hospital for a catchment population of nearly 450,000 inhabitants. Virtually all patients from the area with suspected myositis are referred to Vall d'Hebron, where they are diagnosed, treated, and followed up, whether the disease is severe or not.
All candidate patients are contacted by telephone and invited to participate in the study during a 2-month period. Patients are excluded from the study if they do not meet the diagnostic criteria or are hospitalized for an extremely severe illness, declined to participate, required excessive convincing for participation, deemed likely to play a disruptive role in the group, are younger than 18 years, had severe psychiatric conditions, or had an unfavourable short-term prognosis.
Psychoeducational Intervention The psychoeducational program will be carried out in the experimental group during a two-month period. Control patients do not participate in the intervention, and are treated as usual, and placed on a waiting list to receive the psychoeducational intervention after completion of the study. Patients who receive the intervention had no contact with the control participants. The intervention consists of 5 sessions, with each lasting 100 minutes and delivered on a weekly basis. Individual meetings are conducted with each participant prior to starting the group work. These are considered pre-intervention sessions, during which patients provided informed consent to participate in the study and the first assessment tests is administered.
Two specialized professionals participate in the group sessions: a leader and an external observer present during the process. The leader positioned herself within the group ecology, facilitating the dynamics and development of the sessions. The observer, located outside the group ecology, but in the same room, is responsible for preparing complete minutes of each session and detailed observations, recording the topics discussed and the session structure, as well as presences, absences, delays, and critical incidents, among other relevant data.
The duration and structure of each session is constant, with an introduction phase of 30 minutes, a central phase (the most substantial part of each session) of 50 minutes, and a final phase of 20 minutes. The methodological approach used in the study allow for systematic and consistent implementation of the group psychoeducational program. The combination of individual and group sessions, together with the presence of an external observer, provide a comprehensive view of the progression of the participants and the topics covered.
Measures
Participants are required to fill out a series of questionnaires related with the objectives of the study at 2 time points: before the start of the intervention and on the last day of the intervention. The control group, which do not participate in the intervention, filled out the same questionnaires at the same 2 time points. The battery of questionnaires included the following scales:
World Health Organization Quality of Life Measure (WHOQOL-BREF): a comprehensive, generic questionnaire designed to evaluate various aspects of quality of life. The WHOQOL-BREF consists of 26 items, with 24 items covering four domains: physical health, psychological health, social relationships, and environment. Additionally, 2 global questions inquire about overall quality of life and satisfaction with health. Participants rated each item on a 5-point scale, in which higher scores indicate better quality of life. The assessment was based on the experiences of the past 2 weeks. Results from the 4 domains multiplied by 4 gives a score from 0 to 100, with higher scores indicating better quality of life.
The Spanish version of the WHOQOL-BREF has demonstrated good psychometric properties among elderly Spanish individuals, validating its suitability for the study population.
World Health Organization Well-Being Index (WHO-5): a five-item scale used to assess positive well-being experienced over the past 2 weeks. Each item is rated on a 6-point Likert scale, ranging from 0 (indicating at no time) to 5 (representing all of the time). The total score ranges from 0 to 25. The total multiplied by 4 gives a score from 0 to 100, with higher scores indicating a greater sense of well-being. The WHO-5 has shown high reliability [18].
Self-Efficacy to Manage Chronic Disease Scale (Spanish version, SEMCD-S): developed and validated to assess self-management following an intervention conducted in Stanford University's Chronic Disease Self-Management Program. The questionnaire comprises 4 items, and participants rate each item on a scale from 1 (very unsure) to 10 (very sure). The self-efficacy value is determined as the average of the 4 scores obtained. Higher scores on the scale indicates higher levels of self-efficacy. The questionnaire has shown favorable psychometric properties, indicating good reliability.
International Physical Activity Questionnaire - Short Form (IPAQ) (validated Spanish short-form version). This questionnaire assesses types of physical activity according to their intensity levels and the amount of time spent sitting, as individuals engage in their daily routines. These factors are used to estimate the total physical activity in MET-minutes per week and the duration of sitting time. The tool includes inquiries about 3 types of activity-walking, moderate-intensity activities, and vigorous-intensity activities-performed over the last 7 days, along with a question about sitting time. The overall physical activity (PA) score is obtained by summing up the MET-minutes per week for all 3 types of activities. The study classifies the population into 3 PA levels-low, moderate, and high-following the IPAQ guidelines. Test-retest reliability has indicated good stability.
Participant information encompassed sociodemographic data, which comprised age, sex, marital status, household composition, educational background, and employment status. Clinical data, such as age at diagnosis, specific diagnosis, and years of disease follow-up, were also recorded.
Statistical analysis SPSS version 28 (SPSS Software Inc., Chicago, IL) is used for the statistical analyses. The McNemar test is carried out for nominal dependent variables, and repeated measures ANOVA are used for quantitative variables [22]. Eta squared is used as a measure of effect size. Effect size values around 0.01 are considered a small effect, around 0.06 a medium effect, and around 0.14 a large effect.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Active comparator | Behavioral: PsychoeducativeThe intervention consisted of 5 sessions, with each lasting 100 minutes and delivered on a weekly basis. |
| Control group | Placebo comparator | Behavioral: PlaceboThe control group, which do not receive any psychoeducative intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Definite diagnosis of myositis according to the International Myositis Classification Criteria (score > 90)
- Ability to understand the purpose and procedures of the study, and motivation and agreement to participate.
Key exclusion criteria (7 listed)
- Do not meet the diagnostic criteria
- Patients hospitalized for an extremely severe illness
- Patients who declined to participate
- Patients who required excessive convincing for participation
- Patients who deemed likely to play a disruptive role in the group
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PsychoeducativeThe intervention consiste of 5 sessions (Table 1), with each lasting 100 minutes and delivered on a weekly basis. Individual meetings will be conducted with each participant prior to starting the group work. These were considered pre-intervention sessions, during which patients provided informed consent to participate in the study and the first assessment tests were administered. | Behavioural | Experimental group |
| PlaceboThe control group, which do not receive any psychoeducative intervention | Behavioural | Control group |
Primary outcome
Health related quality of life
Time frame: 2 months
WHOQOL-The WHOQOL-BREF consists of 26 items, with 24 items covering four domains: physical health, psychological health, social relationships, and environment. Additionally, 2 global questions inquire about overall quality of life and satisfaction with health. Participants rated each item on a 5-point scale, in which higher scores indicate better quality of life. The assessment was based on the experiences of the past 2 weeks. Results from the 4 domains multiplied by 4 gives a score from 0 to 100, with higher scores indicating better quality of life.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Mar 2024.
- Derived from this study: PubMed 39487522Armadans-Tremolosa I, Palacin-Lois M, Castrechini-Trotta A, Sanduvete-Chaves S, Chacon-Moscoso S, Selva-O'Callaghan A. Effectiveness of a psychoeducational intervention on myositis patients' quality of life and well-being: a randomized controlled trial. Orphanet J Rare Dis. 2024 Nov 1;19(1):411. doi: 10.1186/s13023-024-03426-0.
- Individual participant dataSharing planned: No
Related trials for Quality of Life
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Cancer, Survivorship
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Albert S Selva-O'Callaghan, Prof principal investigator
Vall d'Hebron General Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychoeducative in people with Quality of Life and Myositis, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Health related quality of life (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06300983, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2024.